Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name…
History, Research, Companies & Products
Explore the main themes, entities and connections around Sanofi. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
company diabetes acq marketed announced billion inc million type regeneron would aventis mellitus cancer vaccine sanofi-synthélabo pharmaceuticals us merged 2004
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Sanofi | Area served | Worldwide | 1.00 | infobox |
| Sanofi | Formerly | Sanofi-Synthélabo (1999–2004) | 1.00 | infobox |
| Sanofi | Formerly | Sanofi-Aventis (2004–2011) | 1.00 | infobox |
| Sanofi | Founded | 15 February 1973; 53 years ago (1973-02-15) | 1.00 | infobox |
| Sanofi | Headquarters | Paris, France | 1.00 | infobox |
| Sanofi | Industry | Pharmaceuticals | 1.00 | infobox |
| Sanofi | Industry | Biotechnology | 1.00 | infobox |
| Sanofi | Industry | Healthcare | 1.00 | infobox |
| Sanofi | ISIN | FR0000120578 | 1.00 | infobox |
| Sanofi | Key people | Frédéric Oudéa (chairman) | 1.00 | infobox |
| Sanofi | Key people | Olivier Charmeil (Interim CEO) | 1.00 | infobox |
| Sanofi | Net income | €7.85 billion (2025) | 1.00 | infobox |
| Sanofi | Number of employees | 82,878 (2024) | 1.00 | infobox |
| Sanofi | Operating income | €6.34 billion (2025) | 1.00 | infobox |
| Sanofi | Products | Medications, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...) | 1.00 | infobox |
| Sanofi | Revenue | €43.62 billion (2025) | 1.00 | infobox |
| Sanofi | Subsidiaries | Sanofi Pasteur | 1.00 | infobox |
| Sanofi | Subsidiaries | Genzyme | 1.00 | infobox |
| Sanofi | Subsidiaries | Shantha Biotechnics | 1.00 | infobox |
| Sanofi | Subsidiaries | Chattem | 1.00 | infobox |
| Sanofi | Subsidiaries | Ablynx | 1.00 | infobox |
| Sanofi | Subsidiaries | Bioverativ | 1.00 | infobox |
| Sanofi | Subsidiaries | Opella | 1.00 | infobox |
| Sanofi | Total assets | €126.80 billion (2025) | 1.00 | infobox |
| Sanofi | Total equity | €71.71 billion (2025) | 1.00 | infobox |
| Sanofi | Traded as | Euronext Paris: SAN | 1.00 | infobox |
| Sanofi | Traded as | Nasdaq: SNY | 1.00 | infobox |
| Sanofi | Traded as | CAC 40 component | 1.00 | infobox |
| Sanofi | Type | Public | 1.00 | infobox |
| Sanofi | Website | sanofi.com | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.